Keywords: glaxosmithkline, sees, flattish, 2nd-qtr, results, sales, helped
GlaxoSmithKline sees flattish 2nd-qtr results, but sales helped by Advair
Article | 30 July 2007
Global number two drugmaker GlaxoSmithKline beat analysts' consensus forecasts, despite posting lackluster results for the second quarter of 2007, against a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
